BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33352155)

  • 1. Design, synthesis, characterization, enzymatic inhibition evaluations, and docking study of novel quinazolinone derivatives.
    Pedrood K; Sherafati M; Mohammadi-Khanaposhtani M; Asgari MS; Hosseini S; Rastegar H; Larijani B; Mahdavi M; Taslimi P; Erden Y; Günay S; Gulçin İ
    Int J Biol Macromol; 2021 Feb; 170():1-12. PubMed ID: 33352155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, α-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1,3,5-triazine structural motifs.
    Lolak N; Akocak S; Türkeş C; Taslimi P; Işık M; Beydemir Ş; Gülçin İ; Durgun M
    Bioorg Chem; 2020 Jul; 100():103897. PubMed ID: 32413628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
    Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and α-glycosidase inhibitors.
    Burmaoglu S; Yilmaz AO; Polat MF; Kaya R; Gulcin İ; Algul O
    Bioorg Chem; 2019 Apr; 85():191-197. PubMed ID: 30622011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. meta-Cyanobenzyl substituted benzimidazolium salts: Synthesis, characterization, crystal structure and carbonic anhydrase, α-glycosidase, butyrylcholinesterase, and acetylcholinesterase inhibitory properties.
    Türker F; Barut Celepci D; Aktaş A; Taslimi P; Gök Y; Aygün M; Gülçin İ
    Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800029. PubMed ID: 29963738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology-oriented drug synthesis and evaluation of secnidazole esters as novel enzyme ınhibitors.
    Ansari MA; Saad SM; Khan KM; Salar U; Taslimi P; Taskın-Tok T; Saleem F; Jahangir S
    Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100376. PubMed ID: 34862640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and discovery of potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase, and α-glycosidase enzymes inhibitors: The novel N,N'-bis-cyanomethylamine and alkoxymethylamine derivatives.
    Taslimi P; Caglayan C; Farzaliyev V; Nabiyev O; Sujayev A; Turkan F; Kaya R; Gulçin İ
    J Biochem Mol Toxicol; 2018 Apr; 32(4):e22042. PubMed ID: 29457667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, bioactivity and binding energy calculations of novel 3-ethoxysalicylaldehyde based thiosemicarbazone derivatives.
    Ishaq M; Taslimi P; Shafiq Z; Khan S; Ekhteiari Salmas R; Zangeneh MM; Saeed A; Zangeneh A; Sadeghian N; Asari A; Mohamad H
    Bioorg Chem; 2020 Jul; 100():103924. PubMed ID: 32442818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New quinoxalin-1,3,4-oxadiazole derivatives: Synthesis, characterization, in vitro biological evaluations, and molecular modeling studies.
    Mirzazadeh R; Asgari MS; Barzegari E; Pedrood K; Mohammadi-Khanaposhtani M; Sherafati M; Larijani B; Rastegar H; Rahmani H; Mahdavi M; Taslimi P; Üç EM; Gulçin İ
    Arch Pharm (Weinheim); 2021 Sep; 354(9):e2000471. PubMed ID: 33999440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological activity and docking calculations of bis-naphthoquinone derivatives from Lawsone.
    Riaz MT; Yaqub M; Shafiq Z; Ashraf A; Khalid M; Taslimi P; Tas R; Tuzun B; Gulçin İ
    Bioorg Chem; 2021 Sep; 114():105069. PubMed ID: 34134033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of chalcone-imide derivatives and investigation of their anticancer and antimicrobial activities, carbonic anhydrase and acetylcholinesterase enzymes inhibition profiles.
    Kocyigit UM; Budak Y; Gürdere MB; Ertürk F; Yencilek B; Taslimi P; Gülçin İ; Ceylan M
    Arch Physiol Biochem; 2018 Feb; 124(1):61-68. PubMed ID: 28792233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization, biological evaluation, and in silico studies of novel 1,3-diaryltriazene-substituted sulfathiazole derivatives.
    Işık M; Akocak S; Lolak N; Taslimi P; Türkeş C; Gülçin İ; Durgun M; Beydemir Ş
    Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000102. PubMed ID: 32529657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, molecular docking and biological activities of novel pyrazoline derivatives.
    Turkan F; Cetin A; Taslimi P; Karaman HS; Gulçin İ
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800359. PubMed ID: 31125504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: Synthesis, biological evaluation and radiosensitizing activity.
    Soliman AM; Ghorab MM; Bua S; Supuran CT
    Eur J Med Chem; 2020 Aug; 200():112449. PubMed ID: 32485534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro inhibitory effects of some acetophenone derivatives on some metabolic enzymes and molecular docking.
    Taslimi P
    Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000210. PubMed ID: 32876951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel amides of 1,1-bis-(carboxymethylthio)-1-arylethanes: Synthesis, characterization, acetylcholinesterase, butyrylcholinesterase, and carbonic anhydrase inhibitory properties.
    Taslimi P; Osmanova S; Caglayan C; Turkan F; Sardarova S; Farzaliyev V; Sujayev A; Sadeghian N; Gulçin İ
    J Biochem Mol Toxicol; 2018 Sep; 32(9):e22191. PubMed ID: 29992664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitors.
    Turkan F; Cetin A; Taslimi P; Karaman M; Gulçin İ
    Bioorg Chem; 2019 May; 86():420-427. PubMed ID: 30769267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinoline-based promising anticancer and antibacterial agents, and some metabolic enzyme inhibitors.
    Ökten S; Aydın A; Koçyiğit ÜM; Çakmak O; Erkan S; Andac CA; Taslimi P; Gülçin İ
    Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000086. PubMed ID: 32537757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel sulfamate derivatives of menthol: Synthesis, characterization, and cholinesterases and carbonic anhydrase enzymes inhibition properties.
    Daryadel S; Atmaca U; Taslimi P; Gülçin İ; Çelik M
    Arch Pharm (Weinheim); 2018 Nov; 351(11):e1800209. PubMed ID: 30255953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 2-methylimidazolium salts: Synthesis, characterization, molecular docking, and carbonic anhydrase and acetylcholinesterase inhibitory properties.
    Bal S; Kaya R; Gök Y; Taslimi P; Aktaş A; Karaman M; Gülçin İ
    Bioorg Chem; 2020 Jan; 94():103468. PubMed ID: 31791684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.